Regeneron Pharmaceuticals reported $3.35B in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4441M 338M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Agenus AGEN:US $ -66.4M 25.02M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Astellas Pharma 4503:JP Y 36090M 59509M
AstraZeneca AZN:LN 1.13B 768M
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Bristol Myers Squibb BMY:US $ 1715M 36M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Johnson & Johnson JNJ:US $ 3849M 2813M
Kyowa Hakko Kirin 4151:JP Y 14682M 866M
Merk MRK:US $ 1497M 1517M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NOVN:VX 3.48B 1.06B
Novartis NVS:US $ 3479M 1064M
Pfizer PFE:US $ 5914M 397M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Teva Pharmaceutical TEVA:IT 582M 148M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
United Therapeutics UTHR:US $ 219.9M 284.7M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M